News
15h
Pharmaceutical Technology on MSNFDA awards RMAT status to 4DMT diabetic macular oedema therapyThe therapy leverages the company’s intravitreal vector, R100, invented using the Therapeutic Vector Evolution platform.
Diabetic retinopathy doesn’t show signs at an early stage and can lead to complete vision loss. The tool helps with timely ...
While many studies have focused on generating high-fidelity synthetic images for beneficial applications, very few have ...
Every year, millions of people around the world undergo detailed and time-consuming examinations to assess the health and ...
Medtech: In the 21st century, ‘Artificial Intelligence (AI)’ is not a buzzword—it is the brain of modern medicine. As the healthcare landscape evolves, AI has become the key driver of digital health, ...
Usually referred to as diabetic retinopathy, the chronic illness can cause the blood vessels of our eyes to bleed or even leak yellow fluid into our eyes, thus leading to the appearance of yellow eyes ...
“These advanced procedures addressed critical cases of Advanced Diabetic Retinopathy, Retinal Detachment, and Ocular Trauma. One of the most notable cases was that of a two-month-old baby born ...
Firstpost spoke to Dr Rakesh Seenappa, Regional Head of Retina Services at Dr Agarwal’s Eye Hospital (Bengaluru) to understand how diabetic retinopathy develops, its warning signs and the latest ...
This unchecked epidemic is driving a sharp rise in diabetic retinopathy cases - where prolonged high blood sugar progressively damages retinal blood vessels, potentially leading to permanent vision ...
PUDUCHERRY: In a major breakthrough, researchers at Pondicherry University have identified molecular markers in tear fluid that could enable early, non-invasive detection of diabetic retinopathy ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results